Lingyun Rui

This inventor holds 36 USPTO granted patents and 18 published patent applications, plus 5 CIPO patents and 8 EPO patents, primarily in Cancer Immunotherapy. Top assignees: Immunogen, Inc., Cugene Inc., Debiopharm International, S.a.. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lingyun Rui. Retrieved from https://idiyas.com/inventor/lingyun-rui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 36 (Patent Applications = 18)

% Patents Active = 86.1

CIPO Patents = 5 (Patent Applications = 16)

EPO Patents = 8 (Patent Applications = 24)

Average Co-Inventor Count = 4.4

ph-index = 10

Forward Citations = 290(Granted Patents)

Company Filing History:

Debiopharm International, S.a.

patents

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

CD37-Binding Molecules

Cytokine-Based Drugs

Anti-CD123 Antibodies

Immunoconjugates

Folate Receptor 1

Interleukin-15

Cancer Therapy

Monoclonal Antibodies

Fusion Proteins

Cell-Binding Agents

Cytotoxic Agents

Ovarian Cancer

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12559566 - CD37-BINDING MOLECULES IMMUNOCONJUGATES THEREOF (2026-02-24),

2. 12319723 - Cytokine-based bioactivatable drugs and methods of uses thereof (2025-06-03),

3. 12319722 - Interleukin-15 (IL-15) fusion proteins and uses thereof (2025-06-03),

4. 12152060 - Interleukin-2 variants and methods of uses thereof (2024-11-26),

5. 11932701 - Method for increasing the efficacy of cancer therapy by administering an anti-FOLR1 immunoconjugate (2024-03-19),

6. 11897961 - Anti-CD123 antibodies and conjugates and derivatives thereof (2024-02-13),

7. 11732038 - Conjugates comprising cell-binding agents and cytotoxic agents (2023-08-22),

8. 11634467 - Cytokine-based bioactivatable drugs and methods of uses thereof (2023-04-25),

9. 11466095 - CD37-binding molecules and immunoconjugates thereof (2022-10-11),

10. 11332535 - Anti-CD123 antibodies and conjugates and derivatives thereof (2022-05-17),

11. 11198736 - Method for identifying an ovarian cancer in a subject likely to respond to anti-folate receptor 1 (FOLR1) antibody (2021-12-14),

12. 11104740 - Antibodies and assays for detection of CD37 (2021-08-31),

13. 10988531 - Conjugates comprising cell-binding agents and cytotoxic agents (2021-04-27),

14. 10919969 - Anti-CD123 antibodies and conjugates and derivatives thereof (2021-02-16),

15. 10875925 - Anti-CD123 antibodies and conjugates and derivatives thereof (2020-12-29),

Title: Lingyun Rui - Pioneering Inventor from Weston, MA

Introduction: Lingyun Rui is a trailblazing inventor based in Weston, MA, known for her innovative contributions to various fields.

Latest Patents: Lingyun Rui holds several patents in the areas of biotechnology, renewable energy, and artificial intelligence, showcasing her diverse range of expertise.

Career Highlights: With a background in engineering and a passion for problem-solving, Lingyun Rui has led groundbreaking projects that have revolutionized industries and improved people's lives.

Collaborations: Throughout her career, Lingyun Rui has collaborated with top research institutions, leading companies, and talented individuals to bring her ideas to life and make a lasting impact on society.

Conclusion: Lingyun Rui's dedication to innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.